메뉴 건너뛰기




Volumn 14, Issue 5, 2014, Pages

Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in Iran

Author keywords

HB immunogenicity; Hepatitis B; Hepatitis B vaccine; Iran

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

EID: 84899890255     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.17263     Document Type: Article
Times cited : (20)

References (38)
  • 1
    • 77956417628 scopus 로고    scopus 로고
    • Hepatitis B vaccines
    • World Health Organization
    • World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec. 2009;48:405-19.
    • (2009) Wkly Epidemiol Rec. , vol.48 , pp. 405-419
  • 2
    • 55249103335 scopus 로고    scopus 로고
    • The global impact of vaccination against hepatitis B: A historical overview
    • Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26(49):6266-73.
    • (2008) Vaccine. , vol.26 , Issue.49 , pp. 6266-6273
    • Zanetti, A.R.1    Van Damme, P.2    Shouval, D.3
  • 4
    • 0028945294 scopus 로고
    • Risks of chronicity following acute hepatitis B virus infection: A review
    • Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis. 1995;20(4):992-1000.
    • (1995) Clin Infect Dis. , vol.20 , Issue.4 , pp. 992-1000
    • Hyams, K.C.1
  • 5
    • 54049155200 scopus 로고    scopus 로고
    • Benefits of early hepatitis B immunization programs for newborns and infants
    • Van Herck K, Van Damme P. Benefits of early hepatitis B immunization programs for newborns and infants. Pediatr Infect Dis J. 2008;27(10):861-9.
    • (2008) Pediatr Infect Dis J. , vol.27 , Issue.10 , pp. 861-869
    • Van Herck, K.1    Van Damme, P.2
  • 6
    • 61849176483 scopus 로고    scopus 로고
    • Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
    • Chen DS. Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. J Hepatol. 2009;50(4):805-16.
    • (2009) J Hepatol. , vol.50 , Issue.4 , pp. 805-816
    • Chen, D.S.1
  • 7
    • 79953123163 scopus 로고    scopus 로고
    • Hepatitis B virus infection, its sequelae, and prevention by vaccination
    • Huang LM, Lu CY, Chen DS. Hepatitis B virus infection, its sequelae, and prevention by vaccination. Curr Opin Immunol. 2011;23(2):237-43.
    • (2011) Curr Opin Immunol. , vol.23 , Issue.2 , pp. 237-243
    • Huang, L.M.1    Lu, C.Y.2    Chen, D.S.3
  • 8
    • 79953861295 scopus 로고    scopus 로고
    • Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region
    • Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S, Leyssen M, et al. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat. 2011;18(5):369-75.
    • (2011) J Viral Hepat. , vol.18 , Issue.5 , pp. 369-375
    • Poovorawan, Y.1    Chongsrisawat, V.2    Theamboonlers, A.3    Leroux-Roels, G.4    Kuriyakose, S.5    Leyssen, M.6
  • 9
    • 34247209063 scopus 로고    scopus 로고
    • Two decades of universal hepatitis B vaccination in taiwan: Impact and implication for future strategies
    • Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, et al. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology. 2007;132(4):1287-93.
    • (2007) Gastroenterology. , vol.132 , Issue.4 , pp. 1287-1293
    • Ni, Y.H.1    Huang, L.M.2    Chang, M.H.3    Yen, C.J.4    Lu, C.Y.5    You, S.L.6
  • 10
    • 58149105757 scopus 로고    scopus 로고
    • Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report
    • But DY, Lai CL, Lim WL, Fung J, Wong DK, Yuen MF. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. Vaccine. 2008;26(51):6587-91.
    • (2008) Vaccine. , vol.26 , Issue.51 , pp. 6587-6591
    • But, D.Y.1    Lai, C.L.2    Lim, W.L.3    Fung, J.4    Wong, D.K.5    Yuen, M.F.6
  • 11
    • 77957682624 scopus 로고    scopus 로고
    • Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up
    • Roznovsky L, Orsagova I, Kloudova A, Tvrdik J, Kabieszova L, Lochman I, et al. Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up. Infection. 2010;38(5):395-400.
    • (2010) Infection. , vol.38 , Issue.5 , pp. 395-400
    • Roznovsky, L.1    Orsagova, I.2    Kloudova, A.3    Tvrdik, J.4    Kabieszova, L.5    Lochman, I.6
  • 12
    • 54049124753 scopus 로고    scopus 로고
    • Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: A 15-year follow-up study
    • Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J. 2008;27(10):881-5.
    • (2008) Pediatr Infect Dis J. , vol.27 , Issue.10 , pp. 881-885
    • Bialek, S.R.1    Bower, W.A.2    Novak, R.3    Helgenberger, L.4    Auerbach, S.B.5    Williams, I.T.6
  • 13
    • 36749019633 scopus 로고    scopus 로고
    • Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination
    • Salleras L, Dominguez A, Bruguera M, Plans P, Costa J, Cardenosa N, et al. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination. Vaccine. 2007;25(52):8726-31.
    • (2007) Vaccine. , vol.25 , Issue.52 , pp. 8726-8731
    • Salleras, L.1    Dominguez, A.2    Bruguera, M.3    Plans, P.4    Costa, J.5    Cardenosa, N.6
  • 14
    • 80053625745 scopus 로고    scopus 로고
    • Epidemiological impact of mandatory vaccination against hepatitis B in Italian young adults
    • Campagna M, Siddu A, Meloni A, Murru C, Masia G, Coppola RC. Epidemiological impact of mandatory vaccination against hepatitis B in Italian young adults. Hepat Mon. 2011;11(9):750-2.
    • (2011) Hepat Mon. , vol.11 , Issue.9 , pp. 750-752
    • Campagna, M.1    Siddu, A.2    Meloni, A.3    Murru, C.4    Masia, G.5    Coppola, R.C.6
  • 15
    • 84864232156 scopus 로고    scopus 로고
    • Impact of universal vaccination against hepatitis B: The italian model
    • Coppola RC, Meloni A, Campagna M. Impact of universal vaccination against hepatitis B: the italian model. Hepat Mon. 2012;12(7):417-9.
    • (2012) Hepat Mon. , vol.12 , Issue.7 , pp. 417-419
    • Coppola, R.C.1    Meloni, A.2    Campagna, M.3
  • 18
    • 44949143241 scopus 로고    scopus 로고
    • Comparison of seroepidemiology and transmission modes of viral hepatitis B in Iran and Pakistan
    • Alavian SM, Fallahian F, Lankarani KB. Comparison of seroepidemiology and transmission modes of viral hepatitis B in Iran and Pakistan. Hepat Mon. 2008;8(1):51-9.
    • (2008) Hepat Mon. , vol.8 , Issue.1 , pp. 51-59
    • Alavian, S.M.1    Fallahian, F.2    Lankarani, K.B.3
  • 19
    • 0027122046 scopus 로고
    • Expanded Programme on Immunization Global Adisory Group
    • World Health Organization
    • World Health Organization. Expanded Programme on Immunization Global Adisory Group. Wkly Epidemiol Rec. 1992;3:11-6.
    • (1992) Wkly Epidemiol Rec. , vol.3 , pp. 11-16
  • 20
    • 34047108778 scopus 로고    scopus 로고
    • Antibody titer in Iranian children 6 years after hepatitis B vaccine administration
    • Hassan S, Ziba F. Antibody titer in Iranian children 6 years after hepatitis B vaccine administration. Vaccine. 2007;25(17):3511-4.
    • (2007) Vaccine. , vol.25 , Issue.17 , pp. 3511-3514
    • Hassan, S.1    Ziba, F.2
  • 21
    • 34249814624 scopus 로고    scopus 로고
    • Assessment of anti-HBs antigen in 6-to 9-year-old children routinely vaccinated via vaccination program in Iran
    • Hadi N, Hadi N. Assessment of anti-HBs antigen in 6-to 9-year-old children routinely vaccinated via vaccination program in Iran. Med Princ Pract. 2007;16(4):306-9.
    • (2007) Med Princ Pract. , vol.16 , Issue.4 , pp. 306-309
    • Hadi, N.1    Hadi, N.2
  • 23
    • 33751055816 scopus 로고    scopus 로고
    • Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone
    • Kabir A, Alavian SM, Ahanchi N, Malekzadeh R. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatol Res. 2006;36(4):265-71.
    • (2006) Hepatol Res. , vol.36 , Issue.4 , pp. 265-271
    • Kabir, A.1    Alavian, S.M.2    Ahanchi, N.3    Malekzadeh, R.4
  • 24
    • 11944255555 scopus 로고    scopus 로고
    • Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth
    • Saffar MJ, Rezai MS. Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth. Indian Pediatr. 2004;41(12):1232-7.
    • (2004) Indian Pediatr. , vol.41 , Issue.12 , pp. 1232-1237
    • Saffar, M.J.1    Rezai, M.S.2
  • 25
    • 69149096126 scopus 로고    scopus 로고
    • The prevalence of hepatitis B surface antigen and antihepatitis B core antibody in Iran: A population-based study
    • Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and antihepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009;12(3):225-31.
    • (2009) Arch Iran Med. , vol.12 , Issue.3 , pp. 225-231
    • Merat, S.1    Rezvan, H.2    Nouraie, M.3    Jamali, A.4    Assari, S.5    Abolghasemi, H.6
  • 27
    • 77649222511 scopus 로고    scopus 로고
    • High prevalence of chronic hepatitis B infection among injection drug users in Iran: The need to increase vaccination of adults at risk
    • SeyedAlinaghi SA, Kheirandish P, Karami N, Salem S, Shirzad H, Jahani MR, et al. High prevalence of chronic hepatitis B infection among injection drug users in Iran: the need to increase vaccination of adults at risk. Acta Med Iran. 2010;48(1):58-60.
    • (2010) Acta Med Iran. , vol.48 , Issue.1 , pp. 58-60
    • SeyedAlinaghi, S.A.1    Kheirandish, P.2    Karami, N.3    Salem, S.4    Shirzad, H.5    Jahani, M.R.6
  • 28
    • 84899861629 scopus 로고    scopus 로고
    • High prevalence of HBV, HCV, and HIV infections in Gypsy population residing in Shahr-E-Kord
    • Asl SKH, Avijgan M, Mohamadnejad M. High prevalence of HBV, HCV, and HIV infections in Gypsy population residing in Shahr-E-Kord. Popul. 2004;3:4.
    • (2004) Popul. , vol.3 , pp. 4
    • Asl, S.K.H.1    Avijgan, M.2    Mohamadnejad, M.3
  • 29
    • 33644601728 scopus 로고    scopus 로고
    • Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran
    • Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005;11(1-2):62-7.
    • (2005) East Mediterr Health J. , vol.11 , Issue.1-2 , pp. 62-67
    • Zali, M.R.1    Mohammad, K.2    Noorbala, A.A.3    Noorimayer, B.4    Shahraz, S.5
  • 30
    • 0038692894 scopus 로고    scopus 로고
    • The prevalence of hepatitis B carrier state in Khorassan province of Iran
    • Farhat A, Khademi G, Mazlouman SJ. The prevalence of hepatitis B carrier state in Khorassan province of Iran. Saudi Med J. 2003;24(5):549-51.
    • (2003) Saudi Med J. , vol.24 , Issue.5 , pp. 549-551
    • Farhat, A.1    Khademi, G.2    Mazlouman, S.J.3
  • 31
  • 32
    • 67649342221 scopus 로고    scopus 로고
    • Trends in seroprevalence of hepatitis b, hepatitis c, hiv, and syphilis infections in Iranian blood donors from 2003 to 2005
    • Khedmat H, Alavian SM, Miri SM, Amini M, Aboualghasemi H. Trends in seroprevalence of hepatitis b, hepatitis c, hiv, and syphilis infections in Iranian blood donors from 2003 to 2005. Hepat Mon. 2009;9(1):24-8.
    • (2009) Hepat Mon. , vol.9 , Issue.1 , pp. 24-28
    • Khedmat, H.1    Alavian, S.M.2    Miri, S.M.3    Amini, M.4    Aboualghasemi, H.5
  • 34
    • 80053620908 scopus 로고    scopus 로고
    • Hepatitis C and hepatitis B virus infection: Epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran
    • Mohebbi SR, Sanati A, Cheraghipour K, Rostami Nejad M, Shalmani HM, Zali MR. Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran. Hepat Mon. 2011;11(9):736-9.
    • (2011) Hepat Mon. , vol.11 , Issue.9 , pp. 736-739
    • Mohebbi, S.R.1    Sanati, A.2    Cheraghipour, K.3    Rostami Nejad, M.4    Shalmani, H.M.5    Zali, M.R.6
  • 35
    • 70449730766 scopus 로고    scopus 로고
    • Prevalence of chronic hepatitis B infection in Iran: A review article
    • Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: a review article. J Res Med Sci. 2009;14(4):249-58.
    • (2009) J Res Med Sci. , vol.14 , Issue.4 , pp. 249-258
    • Poorolajal, J.1    Majdzadeh, R.2
  • 36
    • 34548643049 scopus 로고    scopus 로고
    • Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth
    • Jafarzadeh A, Montazerifar SJ. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. J Ayub Med Coll Abbottabad. 2006;18(4):4-9.
    • (2006) J Ayub Med Coll Abbottabad. , vol.18 , Issue.4 , pp. 4-9
    • Jafarzadeh, A.1    Montazerifar, S.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.